267 related articles for article (PubMed ID: 38323824)
1. Co-resistance to isoniazid and second-line anti-tuberculosis drugs in isoniazid-resistant tuberculosis at a tertiary care hospital in Thailand.
Prommi A; Wongjarit K; Petsong S; Somsukpiroh U; Faksri K; Kawkitinarong K; Payungporn S; Rotcheewaphan S
Microbiol Spectr; 2024 Mar; 12(3):e0346223. PubMed ID: 38323824
[TBL] [Abstract][Full Text] [Related]
2. Isoniazid resistance profile and associated levofloxacin and pyrazinamide resistance in rifampicin resistant and sensitive isolates/from pulmonary and extrapulmonary tuberculosis patients in Pakistan: A laboratory based surveillance study 2015-19.
Tahseen S; Khanzada FM; Rizvi AH; Qadir M; Ghazal A; Baloch AQ; Mustafa T
PLoS One; 2020; 15(9):e0239328. PubMed ID: 32966321
[TBL] [Abstract][Full Text] [Related]
3. Occurrence of disputed rpoB mutations among Mycobacterium tuberculosis isolates phenotypically susceptible to rifampicin in a country with a low incidence of multidrug-resistant tuberculosis.
Al-Mutairi NM; Ahmad S; Mokaddas E; Eldeen HS; Joseph S
BMC Infect Dis; 2019 Jan; 19(1):3. PubMed ID: 30606116
[TBL] [Abstract][Full Text] [Related]
4. Xpert MTB/XDR for detection of pulmonary tuberculosis and resistance to isoniazid, fluoroquinolones, ethionamide, and amikacin.
Pillay S; Steingart KR; Davies GR; Chaplin M; De Vos M; Schumacher SG; Warren R; Theron G
Cochrane Database Syst Rev; 2022 May; 5(5):CD014841. PubMed ID: 35583175
[TBL] [Abstract][Full Text] [Related]
5. Accuracy of whole genome sequencing versus phenotypic (MGIT) and commercial molecular tests for detection of drug-resistant Mycobacterium tuberculosis isolated from patients in Brazil and Mozambique.
Feliciano CS; Namburete EI; Rodrigues Plaça J; Peronni K; Dippenaar A; Warren RM; Silva WA; Bollela VR
Tuberculosis (Edinb); 2018 May; 110():59-67. PubMed ID: 29779775
[TBL] [Abstract][Full Text] [Related]
6. Whole-genome sequencing in drug susceptibility testing of Mycobacterium tuberculosis in routine practice in Lyon, France.
Genestet C; Hodille E; Berland JL; Ginevra C; Bryant JE; Ader F; Lina G; Dumitrescu O;
Int J Antimicrob Agents; 2020 Apr; 55(4):105912. PubMed ID: 31991222
[TBL] [Abstract][Full Text] [Related]
7. Genotypic drug resistance using whole-genome sequencing of Mycobacterium tuberculosis clinical isolates from North-western Tanzania.
Kidenya BR; Mshana SE; Fitzgerald DW; Ocheretina O
Tuberculosis (Edinb); 2018 Mar; 109():97-101. PubMed ID: 29559127
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the broth microdilution plate methodology for susceptibility testing of Mycobacterium tuberculosis in Peru.
Puyén ZM; Santos-Lázaro D; Vigo AN; Coronel J; Alarcón MJ; Cotrina VV; Moore DAJ
BMC Infect Dis; 2022 Aug; 22(1):705. PubMed ID: 36002805
[TBL] [Abstract][Full Text] [Related]
9. Clonal expansion of Mycobacterium tuberculosis isolates and coexisting drug resistance in patients newly diagnosed with pulmonary tuberculosis in Hanoi, Vietnam.
Hung NV; Ando H; Thuy TT; Kuwahara T; Hang NT; Sakurada S; Thuong PH; Lien LT; Keicho N
BMC Res Notes; 2013 Nov; 6():444. PubMed ID: 24188178
[TBL] [Abstract][Full Text] [Related]
10. Role of the first WHO mutation catalogue in the diagnosis of antibiotic resistance in Mycobacterium tuberculosis in the Valencia Region, Spain: a retrospective genomic analysis.
García-Marín AM; Cancino-Muñoz I; Torres-Puente M; Villamayor LM; Borrás R; Borrás-Máñez M; Bosque M; Camarena JJ; Colomer-Roig E; Colomina J; Escribano I; Esparcia-Rodríguez O; Gil-Brusola A; Gimeno C; Gimeno-Gascón A; Gomila-Sard B; González-Granda D; Gonzalo-Jiménez N; Guna-Serrano MR; López-Hontangas JL; Martín-González C; Moreno-Muñoz R; Navarro D; Navarro M; Orta N; Pérez E; Prat J; Rodríguez JC; Ruiz-García MM; Vanaclocha H; ; González-Candelas F; Furió V; Comas I
Lancet Microbe; 2024 Jan; 5(1):e43-e51. PubMed ID: 38061383
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and genetic profiles of isoniazid resistance in tuberculosis patients: A multicountry analysis of cross-sectional data.
Dean AS; Zignol M; Cabibbe AM; Falzon D; Glaziou P; Cirillo DM; Köser CU; Gonzalez-Angulo LY; Tosas-Auget O; Ismail N; Tahseen S; Ama MCG; Skrahina A; Alikhanova N; Kamal SMM; Floyd K
PLoS Med; 2020 Jan; 17(1):e1003008. PubMed ID: 31961877
[TBL] [Abstract][Full Text] [Related]
12. Detection of mutations associated with multidrug-resistant Mycobacterium tuberculosis clinical isolates.
Nimri L; Samara H; Batchoun R
FEMS Immunol Med Microbiol; 2011 Aug; 62(3):321-7. PubMed ID: 21569121
[TBL] [Abstract][Full Text] [Related]
13. Genotypic and phenotypic drug resistance patterns of Mycobacterium tuberculosis isolated from presumptive pulmonary tuberculosis patients in Ethiopia: A multicenter study.
Yenew B; Kebede A; Alemu A; Diriba G; Mehammed Z; Amare M; Dagne B; Sinshaw W; Tesfaye E; Beyene D; Abegaz WE
PLoS One; 2024; 19(5):e0303460. PubMed ID: 38753615
[TBL] [Abstract][Full Text] [Related]
14. Comparisons of whole-genome sequencing and phenotypic drug susceptibility testing for Mycobacterium tuberculosis causing MDR-TB and XDR-TB in Thailand.
Faksri K; Kaewprasert O; Ong RT; Suriyaphol P; Prammananan T; Teo YY; Srilohasin P; Chaiprasert A
Int J Antimicrob Agents; 2019 Aug; 54(2):109-116. PubMed ID: 30981926
[TBL] [Abstract][Full Text] [Related]
15. Whole genome sequencing of drug resistant Mycobacterium tuberculosis isolates from a high burden tuberculosis region of North West Pakistan.
Jabbar A; Phelan JE; de Sessions PF; Khan TA; Rahman H; Khan SN; Cantillon DM; Wildner LM; Ali S; Campino S; Waddell SJ; Clark TG
Sci Rep; 2019 Oct; 9(1):14996. PubMed ID: 31628383
[TBL] [Abstract][Full Text] [Related]
16. Discordance across Phenotypic and Molecular Methods for Drug Susceptibility Testing of Drug-Resistant Mycobacterium tuberculosis Isolates in a Low TB Incidence Country.
Ahmad S; Mokaddas E; Al-Mutairi N; Eldeen HS; Mohammadi S
PLoS One; 2016; 11(4):e0153563. PubMed ID: 27096759
[TBL] [Abstract][Full Text] [Related]
17. First-line anti-tuberculosis drug resistance trends of Mycobacterium tuberculosis complex isolates. A tertiary hospital study in Turkey.
Yazısız H; Hırçın Cenger D; Yazısız V; Kılıç L; Altın S
Tuberk Toraks; 2019 Jun; 67(2):92-101. PubMed ID: 31414639
[TBL] [Abstract][Full Text] [Related]
18. Whole-genome sequencing of clinical isolates from tuberculosis patients in India: real-world data indicates a high proportion of pre-XDR cases.
Bhanushali A; Atre S; Nair P; Thandaseery GA; Shah S; Kuruwa S; Zade A; Nikam C; Gomare M; Chatterjee A
Microbiol Spectr; 2024 May; 12(5):e0277023. PubMed ID: 38597637
[TBL] [Abstract][Full Text] [Related]
19. Molecular Screening Versus Phenotypic Susceptibility Testing of Multidrug-Resistant Mycobacterium tuberculosis Isolates for Streptomycin and Ethambutol.
Al-Mutairi NM; Ahmad S; Mokaddas E
Microb Drug Resist; 2018 Sep; 24(7):923-931. PubMed ID: 29336677
[TBL] [Abstract][Full Text] [Related]
20. Initial resistance to companion drugs should not be considered an exclusion criterion for the shorter multidrug-resistant tuberculosis treatment regimen.
Lempens P; Decroo T; Aung KJM; Hossain MA; Rigouts L; Meehan CJ; Van Deun A; de Jong BC
Int J Infect Dis; 2020 Nov; 100():357-365. PubMed ID: 32829049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
